The DUSP3 Knockout HeLa Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population designed for targeted disruption of the DUSP3 gene, encoding the dual-specificity phosphatase VHR. This polyclonal knockout product is generated via CRISPR/Cas9-mediated gene disruption, resulting in a heterogeneous pool of HeLa cells with loss-of-function mutations in DUSP3, providing a robust model for studying phosphatase-dependent signaling regulation without clonal selection biases.
HeLa cells, derived from HPV18-positive cervical adenocarcinoma, are an immortal epithelial cell line widely used as a model for cervical carcinoma and general cell biology. These adherent cells exhibit robust growth, high transfection efficiency, and active MAPK pathways, making them an ideal host for investigating DUSP3 function. Their transformed phenotype and well-characterized signaling landscape enable clear interpretation of genotype-phenotype relationships following target-gene knockout.
DUSP3 (VHR) functions as a critical negative regulator of mitogen-activated protein kinase (MAPK) cascades by specifically dephosphorylating both phosphotyrosine and phosphothreonine residues on ERK1/2 (MAPK1/3) and JNK1/2 (MAPK8/9). This dual-specific phosphatase is activated by growth factors and stress stimuli, and its expression is transcriptionally regulated by STAT3. DUSP3 directly interacts with and dephosphorylates MAPK1, MAPK3, MAPK8, and MAPK9, as well as STAT5A and STAT5B, thereby attenuating downstream signaling. By inactivating these kinases, DUSP3 modulates key cellular processes including proliferation, differentiation, and apoptosis, acting as a tumor suppressor or context-dependent oncogene.
In the HeLa context, DUSP3 knockout eliminates its inhibitory constraint on MAPK signaling, leading to sustained activation of ERK and JNK pathways. This hyperactivation is anticipated to enhance proliferative drive, migration capacity, and stress responses, mirroring aspects of aggressive cervical carcinoma. The polyclonal nature of the knockout population introduces a spectrum of genetic perturbations, more closely approximating the genetic heterogeneity observed in tumors and enabling studies of dominant signaling phenotypes. This model is particularly valuable for dissecting DUSP3-dependent regulation of cell cycle progression and survival signals in a cervical cancer background.
These knockout cells are optimally suited for a wide range of experimental applications, including investigation of MAPK/ERK and JNK pathway dynamics, phosphatase substrate identification, and validation of kinase inhibitor specificity. Typical assays include western blotting for phosphorylated ERK1/2 and JNK1/2, proliferation and migration/invasion assays, cell cycle analysis by flow cytometry, and transcriptomic profiling via RNA-seq. The polyclonal knockout population also serves as a platform for drug resistance studies, as DUSP3 loss may alter sensitivity to chemotherapeutic agents and targeted inhibitors. For additional information or to discuss your specific research needs, please contact Ascent Research.
